Welcome!

News Feed Item

FDLI to Honor Baylor-Henry, Bennett, Henteleff and Taylor

Honorees Will Receive Distinguished Service and Leadership Award at Holiday Reception December 12

WASHINGTON, Dec. 11, 2012 /PRNewswire-USNewswire/ -- The Food and Drug Law Institute will honor four outstanding food and drug law professionals with its annual Distinguished Service and Leadership Award: Minnie Baylor-Henry, Alan Bennett, Thomas O. Henteleff and John M. Taylor III.

(Logo: http://photos.prnewswire.com/prnh/20121211/DC27524LOGO)

The honorees will receive their awards at FDLI's Holiday and Leadership Awards Reception December 12 at The Westin Georgetown in Washington, D.C.

FDLI, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. The scope of FDLI includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

The award, established in 1993, is given to individuals who have a record of sustained service, leadership and contribution to the food and drug law community and/or FDLI; or provided an exceptional contribution to FDLI and/or the food and drug law community, for example, through outstanding writing or scholarship, by developing new legal theories and precedents or engaging in significant activities on behalf of the public interest.

All of this year's award recipients exemplify those criteria:

Minnie Baylor-Henry is the Worldwide Vice-President for Regulatory Affairs, Johnson & Johnson (J&J) Medical Devices & Diagnostics. As a former FDA regulator, pharmacist and regulatory leader, she has extensive leadership, regulatory and policy experience from her careers in government, as well as the pharmaceutical and consumer industries. Prior to returning to J&J, she was a National Director for Regulatory & Capital Markets Consulting at Deloitte & Touche, with a practice focus on regulatory life sciences. Prior to Deloitte & Touche, Ms. Baylor-Henry worked in several roles at J&J in the Pharmaceutical and Consumer Sectors: Senior Director for Regulatory Affairs; Vice President, U.S. Medical & Regulatory Affairs; and Global Vice President for OTC Regulatory Affairs for McNeil Consumer Healthcare. During her career at FDA, she had many roles, most notably, FDA's National Health Fraud Coordinator and the Director of the Division of Drug Marketing, Advertising, and Communications (DDMAC) from 1995-1999. As the Director of DDMAC, Ms. Baylor-Henry was responsible for the regulatory oversight of all prescription drug advertising and marketing. She currently serves as Immediate Past Chair of the Food and Drug Law Institute and President-Elect of the Drug Information Association. Ms. Baylor-Henry received her pharmacy degree from Howard University's College of Pharmacy and her law degree from Catholic University's Columbus School of Law. 

Alan Bennett, Managing Partner of the Ropes & Gray DC office, has advised clients on issues involving pharmaceutical marketing and promotion for more than 25 years. Mr. Bennett counsels clients and represents them at FDA and in Congress on many of the critical issues that affect the pharmaceutical industry. He is a recognized expert on the Hatch-Waxman Act and lifecycle management. Mr. Bennett also has extensive experience in biological products, including the new biosimilars legislation, in food additive approvals, orphan drugs, and in over the counter drugs and the procedures used to switch them from prescription to non-prescription status. He began his legal career in the Office of the General Counsel of the Food and Drug Administration, where he was a trial and appellate lawyer and legal advisor to several FDA bureaus. Subsequently he was legislative assistant to the late Senator Jacob Javits and Special Counsel to the Senate Governmental Affairs Committee, where he played a major role in one of the first medical records privacy initiatives. After leaving the Hill, Mr. Bennett co-founded a food and drug boutique firm that was ultimately known as Bennett, Turner and Coleman, which merged into Ropes & Gray in 2002. He received his law degree from Columbia University School of Law (Harlan Fiske Stone Scholar) and BA, with honors, from the University of Connecticut.

Thomas O. Henteleff joined Kleinfeld, Kaplan and Becker in 1969 after spending a year clerking for the honorable David T. Lewis of the United Court of Appeals for the 10th circuit. Mr. Henteleff became a partner of the firm 4 1/2 years after joining the firm and became the firm's managing partner in the 1990s. Since joining KK&B, Mr. Henteleff has been engaged in all aspects of "Food & Drug" law. He represents companies, trade associations, investors and individuals that manufacture, market, invest in, or otherwise have a keen interest with respect to the legal and regulatory requirements pertaining to drugs, medical devices, foods, dietary supplements, cosmetics, pesticides and other consumer products. His practice covers the administration and enforcement of the Federal Food, Drug and Cosmetic Act, the Controlled Substances Act, the Federal Trade Commission Act, the Lanham Act and other related laws. He has been honored by FDA and numerous national and international lawyer rating organizations. Mr. Henteleff has served on FDA 's Grassroots Task Force, FDLI's Advisory Board and Editorial Board, and the Advisory Board of World Pharmaceutical Report. Mr. Henteleff received his law degree from the University of California at Berkeley (Boalt Hall) and B.S., Certificate in Internal Relations, from the University of Utah (magna cum laude).

John M. Taylor III is Counselor to the Commissioner, Office of the Commissioner, FDA. In this role, he advises the Commissioner on a broad range of policy and regulatory issues. He advocates for and advances the Commissioner's priorities related to agency policies and programs. Mr. Taylor leads the development and management of FDA's emergency and crisis management policies and programs. He oversees FDA's participation in counterterrorism and emergency exercises and the coordination of the agency's emergency and crisis situations. Mr. Taylor began his FDA career in 1991 in the Office of the Chief Counsel. While at FDA, he has held several management positions such as: Senior Advisor for Regulatory Policy in the Office of the Commissioner, the Acting Director of the Office of Compliance in the Center for Drug Evaluation and Research, the Director of the Office of Enforcement, and Associate Commissioner for Regulatory Affairs. Outside of his FDA career, Mr. Taylor served as the Executive Vice President – Health for the Biotechnology Industry Organization. Until this appointment, he served as Divisional Vice President – Government Affairs, with Abbott Laboratories. Mr. Taylor received his law degree from the College of William and Mary.

SOURCE Food and Drug Law Institute

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
WebRTC is great technology to build your own communication tools. It will be even more exciting experience it with advanced devices, such as a 360 Camera, 360 microphone, and a depth sensor camera. In his session at @ThingsExpo, Masashi Ganeko, a manager at INFOCOM Corporation, will introduce two experimental projects from his team and what they learned from them. "Shotoku Tamago" uses the robot audition software HARK to track speakers in 360 video of a remote party. "Virtual Teleport" uses a...
SYS-CON Events announced today that App2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. App2Cloud is an online Platform, specializing in migrating legacy applications to any Cloud Providers (AWS, Azure, Google Cloud).
Cloud resources, although available in abundance, are inherently volatile. For transactional computing, like ERP and most enterprise software, this is a challenge as transactional integrity and data fidelity is paramount – making it a challenge to create cloud native applications while relying on RDBMS. In his session at 21st Cloud Expo, Claus Jepsen, Chief Architect and Head of Innovation Labs at Unit4, will explore that in order to create distributed and scalable solutions ensuring high availa...
When shopping for a new data processing platform for IoT solutions, many development teams want to be able to test-drive options before making a choice. Yet when evaluating an IoT solution, it’s simply not feasible to do so at scale with physical devices. Building a sensor simulator is the next best choice; however, generating a realistic simulation at very high TPS with ease of configurability is a formidable challenge. When dealing with multiple application or transport protocols, you would be...
In his session at @DevOpsSummit at 20th Cloud Expo, Kelly Looney, director of DevOps consulting for Skytap, showed how an incremental approach to introducing containers into complex, distributed applications results in modernization with less risk and more reward. He also shared the story of how Skytap used Docker to get out of the business of managing infrastructure, and into the business of delivering innovation and business value. Attendees learned how up-front planning allows for a clean sep...
Internet-of-Things discussions can end up either going down the consumer gadget rabbit hole or focused on the sort of data logging that industrial manufacturers have been doing forever. However, in fact, companies today are already using IoT data both to optimize their operational technology and to improve the experience of customer interactions in novel ways. In his session at @ThingsExpo, Gordon Haff, Red Hat Technology Evangelist, shared examples from a wide range of industries – including en...
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
Detecting internal user threats in the Big Data eco-system is challenging and cumbersome. Many organizations monitor internal usage of the Big Data eco-system using a set of alerts. This is not a scalable process given the increase in the number of alerts with the accelerating growth in data volume and user base. Organizations are increasingly leveraging machine learning to monitor only those data elements that are sensitive and critical, autonomously establish monitoring policies, and to detect...
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. Jack Norris reviews best practices to show how companies develop, deploy, and dynamically update these applications and how this data-first...
Intelligent Automation is now one of the key business imperatives for CIOs and CISOs impacting all areas of business today. In his session at 21st Cloud Expo, Brian Boeggeman, VP Alliances & Partnerships at Ayehu, will talk about how business value is created and delivered through intelligent automation to today’s enterprises. The open ecosystem platform approach toward Intelligent Automation that Ayehu delivers to the market is core to enabling the creation of the self-driving enterprise.
"At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're here to tell the world about our cloud-scale infrastructure that we have at Juniper combined with the world-class security that we put into the cloud," explained Lisa Guess, VP of Systems Engineering at Juniper Networks, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
SYS-CON Events announced today that Grape Up will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Grape Up is a software company specializing in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market across the U.S. and Europe, Grape Up works with a variety of customers from emergi...
"We're a cybersecurity firm that specializes in engineering security solutions both at the software and hardware level. Security cannot be an after-the-fact afterthought, which is what it's become," stated Richard Blech, Chief Executive Officer at Secure Channels, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.